Nuwellis (NASDAQ: NUWE) stock soared over 50% in intraday trading following the release of its Q1 earnings report, which beat expectations.
Nuwellis (NUWE) recently released its first-quarter financial results, showcasing a mixed performance with better-than-expected earnings per share (EPS) but revenues falling below estimates.
The company reported earnings per share of -60 cents, beating the consensus estimate of -93 cents. However, revenues for the quarter totaled $1.9 million, representing a 2% year-over-year increase but falling short of the analyst estimate of $2.12 million.
The primary drivers for the revenue growth included an 11% rise in consumable utilization, particularly in the pediatric sector, which saw a significant 40% increase in revenue. Despite this overall growth, Nuwellis experienced a decline in heart failure revenue by 38% due to reduced utilization and consult sales.
Despite the mixed performance in the first quarter, Nuwellis remains optimistic about its growth prospects. The company forecasts a rise in capital sales in the coming year, supported by a robust pipeline of new accounts. The company ended the quarter with $1.4 million in cash and cash equivalents and recently bolstered its financial position by raising an additional $2.7 million through an underwritten public offering on April 30th.
Nuwellis (NASDAQ: NUWE) Stock Price Action
NUWE stock surged 54.03% to close at $0.2634 on Tuesday. Its value has been increased by 70.60% this week. Trading activity has witnessed 134,348,832 (134.34 million) shares changing hands, well above the average daily volume of 2.79 million.
